{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:08:10Z","timestamp":1791378490277,"version":"4.3.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jogoh.2020.101983","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T12:18:06Z","timestamp":1605183486000},"page":"101983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effect of intrauterine device presence and other factors in medical treatment success of tuboovarian abscess"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-8395","authenticated-orcid":false,"given":"Duygu","family":"Tugrul Ersak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-062X","authenticated-orcid":false,"given":"Burak","family":"Ersak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut Kuntay","family":"Kokanal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jogoh.2020.101983_bib0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bpobgyn.2009.01.010","article-title":"The management of pelvic abscess","volume":"23","author":"Granberg","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.jogoh.2020.101983_bib0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.0001-6349.2005.00509.x","article-title":"Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade","volume":"84","author":"S\u00f8rbye","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.jogoh.2020.101983_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/GRF.0b013e3182714681","article-title":"Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess","volume":"55","author":"Chappell","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2020.101983_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4161394","article-title":"Tubo-ovarian abscesses: epidemiology and predictors for failed response to medical management in an Asian population","volume":"2019","author":"Chan","year":"2019","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jogoh.2020.101983_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000072076","article-title":"Tubo-ovarian abscess in older women: is the woman\u2019s age a risk factor for failed response to conservative treatment?","volume":"55","author":"Halperin","year":"2003","journal-title":"Gynecol Obstet Invest"},{"issue":"3\u20134","key":"10.1016\/j.jogoh.2020.101983_bib0030","first-page":"101","article-title":"Tuboovarian abscess. Factors associated with operative intervention after failed antibiotic therapy","volume":"58","author":"Greenstein","year":"2013","journal-title":"J Reprod Med"},{"issue":"3","key":"10.1016\/j.jogoh.2020.101983_bib0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jmig.2018.06.013","article-title":"Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score","volume":"26","author":"Fouks","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"10.1016\/j.jogoh.2020.101983_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0002-9378(78)90657-9","article-title":"Pelvic abscess in association with intrauterine contraceptive device","volume":"131","author":"Scott","year":"1978","journal-title":"Am J Obstet Gynecol"},{"issue":"9254","key":"10.1016\/j.jogoh.2020.101983_bib0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0140-6736(00)04012-5","article-title":"Risk of clinical pelvic inflammatory disease attributable to an intrauterine device","volume":"357","author":"Shelton","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jogoh.2020.101983_bib0050","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00404-018-4690-z","article-title":"Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study","volume":"297","author":"Kapustian","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"RR\u201303","key":"10.1016\/j.jogoh.2020.101983_bib0055","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jogoh.2020.101983_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101789","article-title":"Tubo-ovarian abscess in postmenopausal women: a systematic review","author":"Gil","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"2","key":"10.1016\/j.jogoh.2020.101983_bib0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462417744099","article-title":"2017 European guideline for the management of pelvic inflammatory disease","volume":"29","author":"Ross","year":"2018","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jogoh.2020.101983_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101807","article-title":"Towards outpatient management of tubo-ovarian abscesses?","author":"Breton","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"5","key":"10.1016\/j.jogoh.2020.101983_bib0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(98)00114-0","article-title":"Characterization of calcified deposits on contraceptive intrauterine devices","volume":"58","author":"Patai","year":"1998","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.jogoh.2020.101983_bib0080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/00016340902893678","article-title":"Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess","volume":"88","author":"Charonis","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogoh.2020.101983_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101714","article-title":"Pelvic inflammatory diseases: updated French guidelines","author":"Brun","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"6","key":"10.1016\/j.jogoh.2020.101983_bib0090","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/0002-9378(91)91436-Z","article-title":"Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum \u03b2-lactam agents versus clindamycin-containing regimens","volume":"164","author":"Reed","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jogoh.2020.101983_bib0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jog.12018","article-title":"Evaluating the risk factors for developing resistance to parenteral therapy for tubo\u2010ovarian abscess: a case\u2013control study","volume":"39","author":"Mizushima","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jogoh.2020.101983_bib0100","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/847041","article-title":"Tuboovarian abscesses: is size associated with duration of hospitalization & complications?","volume":"2010","author":"DeWitt","year":"2010","journal-title":"Obstet Gynecol Int"},{"issue":"4","key":"10.1016\/j.jogoh.2020.101983_bib0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5152\/jtgga.2015.15123","article-title":"The evaluation of risk factors for failed response to conservative treatment in tubo-ovarian abscesses","volume":"16","author":"Akkurt","year":"2015","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"3","key":"10.1016\/j.jogoh.2020.101983_bib0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00404-012-2600-3","article-title":"The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience","volume":"287","author":"Demirtas","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.jogoh.2020.101983_bib0115","first-page":"341","article-title":"Pelvic inflammatory disease. Correlation of severity with CA-125 levels","volume":"41","author":"Moley","year":"1996","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.jogoh.2020.101983_bib0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jmig.2019.04.027","article-title":"Can the need for invasive intervention in tubo-ovarian abscess be predicted? The implication of C-reactive protein measurements","volume":"27","author":"Ribak","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jogoh.2020.101983_bib0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejogrb.2019.05.004","article-title":"The predictive role of CA-125 in the management of tubo-ovarian abscess. A retrospective study","volume":"238","author":"Levin","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"10.1016\/j.jogoh.2020.101983_bib0130","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-18-0203","article-title":"Chronic medical conditions and CA125 levels among women without ovarian cancer","volume":"27","author":"Akinwunmi","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jogoh.2020.101983_bib0135","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5120293","article-title":"Clinical characteristics associated with antibiotic treatment failure for tuboovarian abscesses","volume":"2016","author":"Farid","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jogoh.2020.101983_bib0140","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/01443615.2017.1405927","article-title":"Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery","volume":"38","author":"Karaca","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2020.101983_bib0145","series-title":"Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases. Biology of C reactive protein in health and disease","first-page":"67","author":"Ansar","year":"2016"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720303536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720303536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:40:23Z","timestamp":1777995623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784720303536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2468784720303536"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101983","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of intrauterine device presence and other factors in medical treatment success of tuboovarian abscess","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101983"}}